NSE filing, NSE: INFLUX. Summary written from the filing by ALFA Finder's alert engine.
Influx Healthtech Ltd: key numbers
- Share price
- ₹261.50
- Market cap
- ₹605.4 Cr
- Revenue (annual)
- ₹146.8 Cr
- Net profit (annual)
- ₹20.54 Cr
- P/E (TTM)
- 29.5×Sector 41.3×
- Promoter holding
- 73.53%
- FII holding
- 0.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Influx Healthtech Ltd
All →Influx Healthtech H1 FY27 Results: Net Profit ₹12 Cr, Up 20.0% YoY
Influx Healthtech Ltd reported revenue from operations of ₹85.4 Cr (+27.8% YoY) and net profit of ₹12 Cr (+20.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹12 Cr · +20.0% YoY
Influx Healthtech Legal & Regulatory
NSE imposed a fine of Rs. 1.83 Lakhs on Influx Healthtech for a delay in submitting consolidated financial results for the half year ended March 31, 2026.
- Value
- ₹0.02 Cr
Influx Healthtech Annual General Meeting
Influx Healthtech Limited held its 6th Annual General Meeting on September 18, 2026. The company transacted the business items as per the AGM notice.
Influx Healthtech Other Announcement
Influx Healthtech dispatched letters to shareholders without registered emails with the FY 2025-26 Annual Report weblink and 6th AGM notice. The letters are sent under Regulation 36(1)(b) of the SEBI Listing Regulations.
Influx Healthtech Annual General Meeting
Influx Healthtech Ltd. has announced its 6th Annual General Meeting scheduled for September 18, 2026, and submitted its Annual Report for FY 2025-2026.
Influx Healthtech Board Meeting Outcome
The Board approved the Directors' Report for FY26 and fixed the 6th AGM for September 18, 2026. They also appointed a scrutinizer for the upcoming meeting.
Other debt & borrowing announcements
All →Max Estates Debt & Borrowing: ₹350 Cr
Max Estates' board approved a ₹350 crore corporate guarantee for a wholly-owned subsidiary's term loan. Monitoring agency reports on its QIP and warrant proceeds were also filed.
- Value
- ₹350.0 Cr
Credent Connect N Care Debt & Borrowing: ₹4.5 Cr
Credent Connect N Care's board approved an unsecured inter-corporate loan of Rs 4.50 Crore to Kartavya Healtheon Private Limited. The loan carries 12% compounded interest after 25 November 2026 and gives the lender a right to up to 26% equity.
- Value
- ₹4.50 Cr
Amines & Plasticizers Debt & Borrowing
Amines & Plasticizers invited members to place unsecured deposits under Form DPT-1. Only resident members may subscribe, and the scheme is on the company website.
HEG Advanced Materials Debt & Borrowing: ₹50 Cr
HEG granted subsidiary Replus Engitech an unsecured revolving loan of Rs.50 Crore. It is repayable on demand at 9% interest, at arm's length.
- Value
- ₹50.00 Cr
- Execution
- Repayable on demand
Purple Finance Debt & Borrowing: ₹25 Cr
Purple Finance's finance committee approved issuing up to 25,000 senior secured NCDs aggregating ₹25 Crore on a private placement basis. The debentures carry an 11.50% coupon and a 30-month tenure.
- Value
- ₹25.00 Cr
- Execution
- 30 months from deemed date of allotment
Bloom Industries Debt & Borrowing: ₹113 Cr
Bloom Industries approved pledging 9.40% of Shivom Minerals shares to secure ₹113 Crore NCDs and convened an EGM. The company states no material adverse operational impact.
- Value
- ₹113.0 Cr